These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29863454)

  • 1. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications.
    John BV; Aiken T; Garber A; Thomas D; Lopez R; Patil D; Konjeti VR; Fung JJ; McCollough AJ; Askar M
    Exp Clin Transplant; 2018 Aug; 16(4):439-445. PubMed ID: 29863454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation.
    Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
    Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
    Shaked O; Demetris J; Levitsky J; Feng S; Loza BL; Punch J; Reyes J; Klintmalm G; Jackson W; DesMarais M; Sayre P; Shaked A; Reddy KR
    Transplantation; 2022 Jan; 106(1):106-116. PubMed ID: 33982909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.
    Míková I; Neřoldová M; Hubáček JA; Dlouhá D; Jirsa M; Honsová E; Sticová E; Lánská V; Špičák J; Trunečka P
    Transplantation; 2020 Mar; 104(3):526-534. PubMed ID: 31356578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
    Finkenstedt A; Auer C; Glodny B; Posch U; Steitzer H; Lanzer G; Pratschke J; Biebl M; Steurer M; Graziadei I; Vogel W; Zoller H
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study.
    Trunečka P; Míková I; Dlouhá D; Hubáček JA; Honsová E; Kolesár L; Lánská V; Fraňková S; Šperl J; Jirsa M; Poledne R
    Dig Liver Dis; 2018 May; 50(5):490-495. PubMed ID: 29396131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
    Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ
    Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical associations of posttransplant fatty liver disease.
    Lim LG; Cheng CL; Wee A; Lim SG; Lee YM; Sutedja DS; Da Costa M; Prabhakaran K; Wai CT
    Liver Int; 2007 Feb; 27(1):76-80. PubMed ID: 17241384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
    Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation.
    Satapathy SK; Tran QT; Kovalic AJ; Bontha SV; Jiang Y; Kedia S; Karri S; Mupparaju V; Podila PSB; Verma R; Maluf D; Mas V; Nair S; Eason JD; Bridges D; Kleiner DE
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00302. PubMed ID: 33555168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis after pediatric liver transplant.
    Perito ER; Vase T; Ramachandran R; Phelps A; Jen KY; Lustig RH; Feldstein VA; Rosenthal P
    Liver Transpl; 2017 Jul; 23(7):957-967. PubMed ID: 28426902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.
    Hejlova I; Honsova E; Sticova E; Lanska V; Hucl T; Spicak J; Jirsa M; Trunecka P
    Liver Transpl; 2016 May; 22(5):644-55. PubMed ID: 26707008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
    Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
    Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft Steatosis and Donor Diabetes Mellitus Additively Impact on Recipient Outcomes After Liver Transplantation-A European Registry Study.
    Sonneveld MJ; Parouei F; den Hoed C; de Jonge J; Salarzaei M; Porte RJ; Janssen HLA; de Rosner-van Rosmalen M; Vogelaar S; van der Meer AJ; Maan R; Murad SD; Polak WG; Brouwer WP
    Clin Transplant; 2024 Aug; 38(8):e15437. PubMed ID: 39171566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.
    Kwong AJ; Kim WR; Lake J; Stock PG; Wang CJ; Wetmore JB; Melcher ML; Wey A; Salkowski N; Snyder JJ; Israni AK
    Transplantation; 2023 Feb; 107(2):405-409. PubMed ID: 36042548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steatosis in donor and transplant liver biopsies.
    Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.
    Shaker M; Tabbaa A; Albeldawi M; Alkhouri N
    World J Gastroenterol; 2014 May; 20(18):5320-30. PubMed ID: 24833862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation.
    Chiu KW; Goto S; Nakano T; Hu TH; Chen DW; Huang KT; Hsu LW; Chen CL
    Liver Int; 2018 Dec; 38(12):2287-2293. PubMed ID: 29935100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.